Peers for comparison


Market capitalization
‪191.62 B‬ INRMid cap
87.55 INR
‪6.41 B‬ INR
‪21.71 B‬ INR
‪20.31 M‬
Beta (1Y)
0.69
Last report date
Report period
Earnings release details

Revenue and profit margins grew strongly in H1 FY26, with PAT up 21.6% and EBITDA margin expanding. Expansion in the U.S., Mexico, and Latin America, along with robust cash reserves, positions the company for continued growth and potential acquisitions.

Employees (FY)
‪5.46 K‬
Change (1Y)
−77−1.39%
Revenue / Employee (1Y)
‪3.98 M‬ INR
Net income / Employee (1Y)
‪1.18 M‬ INR

Company info


CEO
Sridhar Ganesan
Headquarters
Chennai
Founded
1990
IPO date
Nov 16, 1994
ISIN
INE475E01026
FIGI
BBG000F1M880
Identifiers
ISIN INE475E01026
CFI code
ESVUFN
Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It offers antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmic, pain management, and anti-ulcer products. The company was founded on April 16, 1990 and is headquartered in Chennai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.03%
Market value‪4.86 M‬
Weight0.12%
Market value‪1.67 M‬
Weight0.01%
Market value‪1.13 M‬
Weight0.13%
Market value‪997.97 K‬
Weight0.22%
Market value‪621.46 K‬
Weight0.06%
Market value‪405.67 K‬
Weight0.02%
Market value‪247.99 K‬
Weight3.27%
Market value‪84.79 K‬

Explore more ETFs 

Frequently asked questions


Caplin Point Laboratories Limited is scheduled to release its next earnings report on Feb 5, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
CAPLIPOINT stock is 3.11% volatile and has beta coefficient of 0.69.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like CAPLIPOINT are typically less volatile than smaller companies

Track every detail on Caplin Point Laboratories Limited stock chart and check out the list of the most volatile stocks — is Caplin Point Laboratories Limited there?
To understand the CAPLIPOINT stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −5.26%
– 1 week — −1.50%
– 1 month — −1.07%

CAPLIPOINT all-time low was 1,221.00 INR (Jun 4, 2024), and its highest price is 2,990.60 INR (Sep 24, 2026). Find more dynamics in the Stock Heatmap and on the Caplin Point Laboratories Limited stock chart.
Caplin Point Laboratories Limited market capitalization is ‪191.62 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Caplin Point Laboratories Limited stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Caplin Point Laboratories Limited stacks up against other companies
The safest way to buy Caplin Point Laboratories Limited stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade CAPLIPOINT directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 13, 2026, the company has ‪5.46 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Caplin Point Laboratories Limited pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.

Its recent dividend yield was around 0.53%, with a payout ratio of 9.48%, compared to 0.30% and 8.50% in the previous period.

What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance

Explore all this in Caplin Point Laboratories Limited financials.
Investing in Caplin Point Laboratories Limited depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Caplin Point Laboratories Limited financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our CAPLIPOINT technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — neutral
– 1-month — strong buy

Combine fundamental and technical analysis for better results.
Caplin Point Laboratories Limited stock ticker depends on the exchange where it’s listed. On the NSE, its primary exchange, Caplin Point Laboratories Limited stocks trade under the symbol CAPLIPOINT.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track Caplin Point Laboratories Limited financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
CAPLIPOINT net income for the last quarter is ‪1.77 B‬ INR, while the quarter before that showed ‪1.70 B‬ INR of net income which accounts for 4.00% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Caplin Point Laboratories Limited financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
CAPLIPOINT reached its all-time high of 2,990.60 INR on Sep 24, 2026. Its all-time low was 1,221.00 INR and was reached on Jun 4, 2024.

Explore the Caplin Point Laboratories Limited stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Caplin Point Laboratories Limited EBITDA is ‪7.97 B‬ INR, with an EBITDA margin of 34.90%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Caplin Point Laboratories Limited statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 2,690.00 INR and 2,690.00 INR for CAPLIPOINT, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance